Terminal
Stocks
Spotlight
Research

Stocks
Healthcare
NASDAQ
IMRN

Market Cap: $9.35M

IL

Immuron Limited

IMRN

NASDAQ (NASDAQ Capital Market)USD

Overview News Analyst Reports Financials Politician Trades Insider Trades Executive Patents Earnings Surprise

By Cashu Finance. Providing market news, analysis, and research for investors worldwide.

Company

Stocks About Advertisers Brokers Contact

Legal

Terms of Service Privacy Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Finance is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Finance is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Finance and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Financials

Profitability

Gross Profit Margin64.50%

EBITDA Margin-61.39%

EBIT Margin-61.39%

Pre-tax Margin-57.85%

Net Profit Margin-49.77%

Earnings Yield-22.69%

Valuation Multiples

Price / Book1.54

Price / Sales1.74

Price / Earnings-4.03

PEG-0.08

Forward PEG-0.15

EV / Sales0.57

EV / EBITDA-0.93

EV / Operating Cash Flow-1.43

EV / Free Cash Flow-1.43

Price / Free Cash Flow-4.37

Price / Operating Cash Flow-5.52

Cash Flow & Capital

Free Cash Flow / Share-$0.38

Operating Cash Flow / Share-$0.38

Free Cash Flow Yield-22.90%

Capex / Revenue0.06%

Capex / Operating Cash Flow-0.16%

Capex / Depreciation0.00

Stock Compensation / Revenue0.00%

Dividend Payout Ratio0.00%

Dividend Yield0.00%

Liquidity & Leverage

Current Ratio7.17

Quick Ratio5.90

Cash Ratio5.05

Debt / Assets0.00

Debt / Capital0.00

Debt / Equity0.00

Long-Term Debt / Capital0.00

Debt / Market Cap0.00%

Net Debt / EBITDA1.90

Solvency Ratio-1.93

Financial Leverage1.18

Efficiency & Working Capital

Asset Turnover0.59

Fixed Asset Turnover40.02

Inventory Turnover1.20

Receivables Turnover6.17

Payables Turnover2.04

Days Sales Outstanding59.17

Days Inventory Outstanding303.07

Days Payables Outstanding179.33

Operating Cycle362.23

Cash Conversion Cycle182.9

Working Capital Turnover0.64

Returns & Quality

Return on Equity-31.88%

Return on Assets-29.54%

Return on Invested Capital-36.35%

ROCE-42.25%

Return on Tangible Assets-29.54%

Operating Return on Assets-33.67%

Income Quality0.80

Tax Burden0.86

Interest Burden0.94

Balance Sheet & Intrinsic Metrics

Enterprise Value$4.39M

Invested Capital$11.21M

Working Capital$11.01M

Tangible Asset Value$11.01M

Net Current Asset Value$10.81M

Graham Net-Net$1.12

Book Value / Share$1.35

Tangible Book Value / Share$1.35

Cash / Share$1.11

Financial Health Scores

Piotroski Score3

Altman Z-Score-5.06

Revenue$12.63M

EBIT$-9.02M

Market Cap$14.62M

Working Capital$11.02M

Retained Earnings$-85.13M

Total Assets$12.99M

Total Liabilities$1.99M